Back
  1. Home
  2. Profile of Erik Teske (ULiège)
Profil

Teske Erik

See author's contact details
Main Referenced Co-authors
Hamaide, Annick  (5)
Clercx, Cécile  (4)
Dourcy, Mickael  (3)
Noël, Stéphanie  (3)
Roels, Elodie  (3)
Main Referenced Keywords
P-glycoprotein (2); ABC transporters (1); ABC-transporters (1); Animals (1); Antineoplastic Agents/administration & dosage/therapeutic use (1);
Main Referenced Unit & Research Centers
FARAH - Fundamental and Applied Research for Animals and Health - ULiège [BE] (3)
Main Referenced Disciplines
Veterinary medicine & animal health (9)

Publications (total 9)

The most downloaded
1085 downloads
Zandvliet, M., Teske, E., & Schrickx, J. A. (2014). Multi-drug resistance in a canine lymphoid cell line due to increased P-glycoprotein expression, a potential model for drug-resistant canine lymphoma. Toxicology in Vitro, 28 (8), 1498-506. doi:10.1016/j.tiv.2014.06.004 https://hdl.handle.net/2268/175529

The most cited

44 citations (Scopus®)

Zandvliet, M., Teske, E., Schrickx, J. A., & Mol, J. A. (2014). A longitudinal study of ABC transporter expression in canine multicentric lymphoma. Veterinary Journal. doi:10.1016/j.tvjl.2014.11.002 https://hdl.handle.net/2268/178688

Shimizu, N., Hamaide, A., Dourcy, M., Noël, S., Clercx, C., & Teske, E. (2018). Evaluation of urinary and serum level of chemokine (C-C motif) ligand 2 as a potential biomarker in canine urothelial tumours. Veterinary and Comparative Oncology. doi:10.1111/vco.12436
Peer Reviewed verified by ORBi

Porato, M., Hamaide, A., Fontaine, C., & Teske, E. (2018). Effects of deslorelin implantation on hepatic gland tumors in intact male dogs: a preliminary study [Poster presentation]. 21th European Veterinary Society for Small Animal Reproduction Annual congress, Venice, Italy.

Shimizu, N., Hamaide, A., Dourcy, M., Noël, S., Roels, E., Clercx, C., & Teske, E. (21 October 2016). Assessment of chemokine CCL2 in canine urogenital tumours and its potential as target for treatment [Poster presentation]. 3rd FARAH Day, Liège, Belgium.

Shimizu, N., Hamaide, A., Dourcy, M., Noël, S., Roels, E., Clercx, C., & Teske, E. (October 2016). Assessment of chemokine CCL2 in canine urogenital tumours and its potential as target for treatment [Paper presentation]. ESVONC Annual congress, Nantes, France.

Roels, E., Holopainen, S., Teske, E., Allerton, F., Bomassi, E., Damoiseaux, C., De Lorenzi, D., Fisher, A., Muller, N., Hendrickx, T., Vrancken, A., Rajamäki, M., & Clercx, C. (11 September 2015). CHEMOKINE (CC-MOTIF) LIGAND 2 AS A PROGNOSTIC SERUM MARKER IN CANINE IDIOPATHIC PULMONARY FIBROSIS [Poster presentation]. ECVIM-CA Congress 2015, Lisboa, Portugal.

Terradas Crespo, De Vreught, L., Hamaide, A., & Teske, E. (2015). Les tumeurs périanales chez le chien: revue de la littérature. Monde Vétérinaire, 148, 35-39.

Teske, E., van Lankveld, A. J., & Rutteman, G. R. (2014). Intraperitoneal antineoplastic drug delivery: experience with a cyclophosphamide, vincristine and prednisolone protocol in cats with malignant lymphoma. Veterinary and Comparative Oncology, 12 (1), 37-46. doi:10.1111/j.1476-5829.2012.00329.x
Peer Reviewed verified by ORBi

Zandvliet, M., Teske, E., Schrickx, J. A., & Mol, J. A. (2014). A longitudinal study of ABC transporter expression in canine multicentric lymphoma. Veterinary Journal. doi:10.1016/j.tvjl.2014.11.002
Peer Reviewed verified by ORBi

Zandvliet, M., Teske, E., & Schrickx, J. A. (2014). Multi-drug resistance in a canine lymphoid cell line due to increased P-glycoprotein expression, a potential model for drug-resistant canine lymphoma. Toxicology in Vitro, 28 (8), 1498-506. doi:10.1016/j.tiv.2014.06.004
Peer Reviewed verified by ORBi

Contact ORBi